Robabeh Rahimi

Associate Professor

University of Maryland
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

About

Robabeh Rahimi is an Associate Professor at the University of Maryland, Baltimore, USA. Her research focuses on enhancing treatment outcomes in radiation therapy, including recent work on 3D-printed bolus for tumor treatment and the systematic characterization of radiochromic films. She is also involved in fetal dose assessments during proton therapy and initiatives to improve proton therapy standards.

Articles (11)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Background Quantum computing (QC) is emerging as a transformative tool for solving complex optimization problems across various fields, including biomedical applications. While classical optimization methods are well‐established, they frequently face limitations when applied to complex and large‐scale problems in radiotherapy planning. Purpose This study aims to explore the implementation and evaluate the effectiveness of quantum optimization methods, specifically quantum annealing and the quantum approximate optimization algorithm (QAOA), in radiotherapy planning. In particular, we employ an Ising Hamiltonian formulation of the cost function, empirically implementing it on annealing‐based quantum hardware and for the first time on circuit‐based one. Methods We formulated a simplified radiotherapy optimization problem and solved it using quantum annealing on a D‐Wave quantum annealer. Subsequently, we adapted this optimization problem for the QAOA framework and implemented it on IBM Quantum circuit‐model hardware. Comparative analyses were conducted between classical and quantum methods and implementations, highlighting QC's potential advantages and limitations in specific optimization contexts. To demonstrate that the Hamiltonian formulation is valid and practically usable, we first tested it in simplified proof‐of‐principle examples and then extended it to a more clinically relevant bilateral prostate proton plan. In this new example, dose parameters were extracted directly from a commercial treatment planning system (RayStation) and incorporated into the Hamiltonian optimization workflow. Both one‐qubit‐per‐voxel and two‐qubits‐per‐voxel encodings were evaluated to illustrate scalability. Additionally, we discussed scalability considerations, practical challenges, and future research directions necessary for integrating quantum algorithms into routine clinical radiation therapy practices. Results To our knowledge, this study presents the first demonstration of using QC circuit‐model hardware for radiotherapy planning optimization. The quantum annealing approach successfully determined the optimal solution. Convergence was achieved after 20 iterations on a quantum simulator (noise free) and after 100 iterations on actual quantum hardware (due to inherent hardware noise). In the bilateral prostate proton plan derived from realistic data, the Hamiltonian‐based optimization assigned higher dose to the prostate relative to surrounding organs‐at‐risk, confirming the feasibility of applying QC optimization directly to clinically sourced parameters. Conclusions Quantum optimization techniques demonstrate potential advantages over classical methods, particularly in complex optimization scenarios relevant to radiation therapy. The formulation of a Hamiltonian cost function, its validation on real quantum hardware, and its application to realistic data collectively represent a first concrete step toward QC‐based treatment planning optimization in medical physics. Future research should focus on addressing scalability, overcoming practical implementation challenges, and advancing the development of scalable, fault‐tolerant quantum systems suitable for clinical integration.

Year:

2026

Traditional boluses for pelvic lesions present challenges, including compromised skin dose coverage from large air gaps in treatment plans and increased uncertainties in treatment delivery due to variations in bolus fitting. This study evaluates the clinical benefits of a patient‐specific, 3D‐printed bolus (pBolus) in external beam radiation therapy (EBRT) for extramammary Paget's disease in the inguinal fold. A three‐dimensional (3D) conformal plan utilizing the pBolus was compared to a conventional Superflab bolus (sBolus) under identical beam arrangements. The pBolus improved dose conformity by reducing air gaps in the treatment plan, and therefore, it was selected for clinical treatment. Weekly setup imaging revealed air gaps predominantly along the inguinal fold, demonstrating overall consistency in bolus fitting with minor air gap variations. Additionally, in vivo dosimetry confirmed dose accuracy. As a result, the patient achieved a favorable outcome, with no clinical evidence of disease at the follow‐up visit.

Year:

2025

Objective . We aim to characterize kinetics of radiation-induced optical density in newly released EBT4 radiochromic films exposed to clinical x-rays. Several film models and batches were evaluated for the film sensitivity, optical signal increasing with time, relative film noise, and minimum detectable limits (MDL). Approach . Radiochromic film pieces from a single batch of EBT3 and three batches of EBT4 were exposed to doses of 77.38 cGy, 386.92 cGy, and 773.84 cGy using a 6 MV x-ray beam. The films were scanned with a flatbed scanner at specific time intervals up to 120 h. The time-series net optical density of red, green and blue colors was corrected for response of the scanner with time and studied to establish the saturation characteristics of film polymerization process. Dose–response from 3.86 cGy to 1935 cGy was also determined for each color. MDL of the films was quantitatively defined as the dose that would double the net optical density of red color above the standard deviation of the residual signal at zero dose. The relative noise characteristics of EBT3 versus EBT4 were studied as a function of time, dose and scanner resolution. Main Results . For doses ≥ 100 cGy, analysis revealed a stability of optical density beyond 48 h post-exposure for EBT3 and EBT4 films. EBT3 films attained 80%-90% of their net optical density at 48 h within minutes of irradiation, compared to 72%-88% for EBT4 films. The rate of growth was slowest for blue color, fastest for red, while green was in between the two. The MDL for EBT4 averaged 15 cGy for three batches, whereas EBT3 films reliably detected doses as low as 8.5 cGy. Significance . Several batches of the new EBT4 film showed slightly lower response compared to its predecessor over 3.86 cGy to 1935 Gy range. For all practical purposes, the post-irradiation growth of polymers ceases between 48 to 60 h for both EBT films. Overall, the EBT4 film exhibited noise characteristics similar to EBT3, except for lower doses where the noise was observed to be higher than its predecessor.

Year:

2025

Purpose Incident learning in large, multi‐site hospital systems faces challenges from resource constraints, diverse site cultures, and deviations from system‐wide policies. This study introduces a novel, resource‐efficient hybrid approach to facilitate cross‐site learning and proactive risk management, ultimately enhancing patient safety. Methods A hybrid approach, integrating statistical, and root cause analyses was used to analyze safety events recorded from 2023 to 2024 at five sites. Events were categorized by time, site, type, and harm score with statistics tracking the event frequency per category. Failure modes (FMs) were identified with summative keywords. The frequency and cross‐site correlation of keywords were innovatively displayed by word clouds. The hybrid approach was exemplified at a high‐throughput satellite clinic, where treatments and incidents were tracked quarterly. A proactive model was also employed to predict the number of potentially affected patients at this site. Results An analysis of 228 reported events revealed that most incidents occurred within the treatment planning category, where the keywords “carepath” and “contour” were identified as the top two frequently reported FMs, repeated 13 and 10 times respectively. The keywords “contour” and “documentation” appeared across four sites, followed by “carepath” and “couch” which appeared across three sites. At the featured satellite clinic, a total of 18 FMs were identified from yearly 8,714 treatments. The proactive model showed an average risk priority number decreased from 106 to 77, and the estimated number of affected patients decreased from 27 to 20 at this site. Conclusions We developed a comprehensive, system‐wide approach that enhanced efficiency in incident learning across multi‐site clinics. Site‐specific shifts in safety culture were effectively benchmarked and cross‐site learning was facilitated through measurable endpoints. A novel word cloud analysis was developed, enhancing visualization of cross‐site root causes. Additionally, a proactive model was adopted to increase system‐wide preparedness and improve patient safety outcomes.

Year:

2025

Purpose The treatment of brain tumors in pregnant patients poses challenges, as the out‐of‐field dose exposure to the fetus can potentially be harmful. A pregnant patient with prior radiation treatment was presented with a brain tumor at our clinic. This work reports on our pre‐treatment study that compared fetal dose exposure between intensity‐modulated proton therapy (IMPT) using pencil beam scanning (PBS) and conventional photon 3D conformal radiation therapy (3DCRT) and volumetric‐modulated arc therapy (VMAT), and the subsequent pregnant patient's radiation treatment. Materials and methods Pre‐treatment measurements of clinical plans, 3DCRT, VMAT, and IMPT, were conducted on a phantom. Measurements were performed using a device capable of neutron detections, closely following AAPM guidelines, TG158. For photon measurements, fetus shielding was utilized. On patient treatment days, which was determined to be proton treatment, shielding was used only during daily imaging for patient setup. Additionally, an in vivo measurement was conducted on the patient. Results Measurements showed that IMPT delivered the lowest fetal dose, considering both photon and neutron out‐of‐field doses to the fetus, even when shielding was implemented for photon measurements. Additionally, the proton plans demonstrated superior treatment for the mother, a reirradiation case. Conclusion The patient was treated with proton therapy, and the baby was subsequently delivered at full term with no complications. This case study supports previous clinical findings and advocates for the expanded use of proton therapy in this patient population.

Year:

2024

Year:

2024

Year:

2023

Collaborators (2)

Jeremy Kunz

Assistant Professor

University of Utah Health Huntsman Cancer Institute

UNITED STATES
View details

Ramin Abolfath

Assistant Professor

Howard University

UNITED STATES
View details